$INTT Cashflow Statement | Understand Stock

$INTT

$14.25 +$0.50 (3.64%) Close

$INTT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) earnings
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Depreciation and amortization
Impairment of right-of-use assets
Provision for excess and obsolete inventory
Foreign exchange (gain) loss
Amortization of deferred compensation related to stock-based awards
Discount on shares sold under Employee Stock Purchase Plan
Proceeds from sale of demonstration equipment, net of gain
Loss on disposal of property and equipment
Deferred income tax benefit
Adjustment to contingent consideration liability
Other non-cash reconciling items

Changes in assets and liabilities:
Trade accounts receivable
Inventories
Prepaid expenses and other current assets
Restricted certificates of deposit
Other assets
Operating lease liabilities
Accounts payable
Accrued wages and benefits
Accrued professional fees
Customer deposits and deferred revenue
Accrued sales commission
Domestic and foreign income taxes payable
Other current liabilities
Deferred revenue, net of current portion
Accrued expenses and other liabilities

Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Payment of contingent consideration related to Z-Sciences acquisition
Refund of final working capital adjustment related to Acculogic
Acquisition of business, net of cash acquired
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchase of short term investments
Sales of short term investments
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Term Note
Net proceeds from public offering of common stock
Repayments of short-term borrowings, net of proceeds
Repayments of long-term debt
Term Note
Total repayments of long-term debt
Proceeds from stock options exercised and shares sold through Employee Stock Purchase Plan
Proceeds from Paycheck Protection Program loans
Repayments of Paycheck Protection Program loans
Proceeds from revolving credit facility
Repayments of revolving credit facility
Repurchases of common stock
Proceeds from stock options exercised
Proceeds from shares sold under Employee Stock Purchase Plan
Settlement of employee tax liabilities in connection with treasury stock transaction
Net cash used in financing activities

Effects of exchange rates on cash
Net cash used in all activities
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash and cash equivalents
Restricted cash
Cash payments for:
Domestic and foreign income taxes
Interest
Total income taxes paid net of refunds received
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Equity issued in conjunction with acquisition of business
Contingent consideration
Goodwill resulting from acquisitions
Net cash paid for acquisitions
Issuance of unvested shares of restricted stock awards
Alfamation
Restricted Stock
Total issuance of unvested shares of restricted stock awards
Forfeiture of unvested shares of restricted stock
Fair value of assets acquired, net of cash
Forfeiture of shares of unvested restricted stock awards

Comments